P302 Serum IL-6 is associated with treatment refractoriness in acute severe ulcerative colitis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjab076.426
Abstract: Response to therapy in acute severe ulcerative colitis (ASUC) is highly variable ranging from steroid response to salvage therapy failure and emergency colectomy. Biomarkers that accurately predict outcomes in ASUC early in the admission may… read more here.
Keywords: serum; treatment; patients asuc; responders ifx ... See more keywords